PREDICTORS OF PRESENTEEISM AND ABSENTEEISM IN PATIENTS COMMENCING TREATMENT WITH METHOTREXATE MONOTHERAPY OR BIOLOGIC THERAPY FOR RHEUMATOID ARTHRITIS

被引：0
|
作者：
Leggett, Sarah [1 ]
Lunt, Mark [1 ]
Barton, Anne [2 ]
Hyrich, Kimme [1 ]
Walker-Bone, Karen [3 ]
Verstappen, Suzanne [1 ]
机构：
[1] Univ Manchester, Arthrit Res UK Ctr Epidemiol, Manchester, Lancs, England
[2] Univ Manchester, Arthrit Res UK Ctr Genet & Genom, Manchester, Lancs, England
[3] Univ Southampton, Arthrit Res UK MRC Ctr Musculoskeletal Hlth & Wor, Southampton, Hants, England
来源：
RHEUMATOLOGY | 2018年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
227
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Predictors of Drug-Free Remission Following Treatment with Abatacept (in Combination with Methotrexate or as Monotherapy) in Early Rheumatoid Arthritis
    Emery, P.
    Burmester, Gerd
    Bykerk, Vivian P.
    Combe, B.
    Furst, D. E.
    Barre, E.
    Karyekar, C. S.
    Wong, D.
    Huizinga, T. W. J.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1084 - S1084
  • [42] PREDICTORS OF DRUG-FREE REMISSION FOLLOWING TREATMENT WITH ABATACEPT (IN COMBINATION WITH METHOTREXATE OR AS MONOTHERAPY) IN EARLY RHEUMATOID ARTHRITIS
    Emery, Paul
    Burmester, Gerd R.
    Bykerk, Vivian P.
    Combe, Bernard G.
    Furst, Daniel E.
    Karyekar, Chetan S.
    Wong, Dennis A.
    Huizinga, Tom W. J.
    RHEUMATOLOGY, 2015, 54 : 28 - 29
  • [43] Beyond methotrexate monotherapy for early rheumatoid arthritis
    Scott, David L.
    LANCET, 2016, 388 (10042): : 309 - 310
  • [44] Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate
    Alberto Batticciotto
    Roberto Ravasio
    Marta Riva
    Piercarlo Sarzi-Puttini
    Advances in Therapy, 2016, 33 : 1360 - 1373
  • [45] Dual Biologic Therapy in Patients with Rheumatoid Arthritis and Psoriatic Arthritis
    Furer, Victoria
    Elkayam, Ori
    RAMBAM MAIMONIDES MEDICAL JOURNAL, 2023, 14 (02):
  • [46] Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate
    Batticciotto, Alberto
    Ravasio, Roberto
    Riva, Marta
    Sarzi-Puttini, Piercarlo
    ADVANCES IN THERAPY, 2016, 33 (08) : 1360 - 1373
  • [47] Predicting the Need for Additional Treatment in Early Rheumatoid Arthritis Patients Treated to Target on Methotrexate Monotherapy
    Teitsma, Xavier
    Jacobs, Johannes
    Welsing, Paco
    Woodworth, Thasia
    Petho-Schramm, Attila
    Borm, Michelle
    Bernasconi, Corrado
    Lafeber, Floris
    Bijlsma, Johannes W. J.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [48] Investigating Psychological Predictors of Biologic Treatment Response in Patients with Severe Active Rheumatoid Arthritis
    England, Bethan
    Cordingley, Lis
    Plant, Darren
    Morgan, Ann
    Wilson, Anthony
    Hyrich, Kimme L.
    Barton, Anne
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [49] Factors associated with commencing and ceasing opioid therapy in patients with rheumatoid arthritis
    Black, Rachel J.
    Richards, Bethan
    Lester, Susan
    Buchbinder, Rachelle
    Barrett, Claire
    Lassere, Marissa
    March, Lyn
    Hill, Catherine L.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 49 (03) : 351 - 357
  • [50] Biologic and Glucocorticoid Use after Methotrexate Initiation in Patients with Rheumatoid Arthritis
    George, Michael D.
    Sauer, Brian C.
    Teng, Chia-Chen
    Cannon, Grant W.
    England, Bryant R.
    Kerr, Gail S.
    Mikuls, Ted R.
    Baker, Joshua F.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (04) : 343 - 350
12345